The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis

Masahiro Tojo, Tadao Oikawa, Yoshiyuki Morikawa, Naoya Yamashita, Satoshi Iwata, Yoshitake Satoh, Juhei Hanada, Ryuichiro Tanaka

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)


We studied the effects of Bifidobacterium breve on Campylobacter enteritis. Patients with Campylobacter enteritis were divided into three groups (I. Erythromycin recipients; II. B. breve recipients; III. control) and studied with regard to the duration of diarrhea and carriage of Campylobacter jejuni in the stools. Additional studies were performed to observe the effects of B. breve on fecal flora. The results showed that there were no significant differences in the duration of diarrhea among the three groups. Comparison of the duration of C. jejuni carriage in the stools was as follows: KIKIII (P<0.01). Microbiological study of fecal flora demonstrated that the number of bifidobacterium was decreased in Campylobacter enteritis compared to the control, and an increase in the number of bifidobacterium could be recognized after the administration of B. breve. B. breve was useful in eradicating C. jejuni from the stools and restoring the normal intestinal flora in Campylobacter enteritis, although if was not effective in shortening the duration of diarrhea.

Original languageEnglish
Pages (from-to)160-167
Number of pages8
JournalPediatrics International
Issue number1
Publication statusPublished - 1987


  • Bifidobacterium breve
  • Campylobacter enteritis
  • Erythromycin
  • Intestinal flora

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis'. Together they form a unique fingerprint.

Cite this